Progesterone and progesterone receptors (PRs) are essential for the development and
cyclical regulation of hormone-responsive tissues including the breast and reproductive …

The development of adverse outcome pathways (AOPs) is becoming a key component of
twenty-first century toxicology. AOPs provide a conceptual framework that links the …

The progesterone receptor (PGR) is a nuclear receptor transcription factor that is essential
for female fertility, in part due to its control of oocyte release from the ovary, or ovulation. In …

This ninety-first volume of IARC Monographscontains evaluations of the carcinogenic
hazard to humans of combined estrogen-progestogen contraceptives and combined …

Progesterone receptors (PRs) are implicated in various cancers since their
presence/absence can determine clinical outcomes. The overstimulation of progesterone …

Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …

Lymphocytes and myeloid cells express estrogen, progesterone, and androgen receptors,
and studies show that sex steroid hormones directly modulate their activation, lifespan, and …

Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or
the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic …

Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …

OBJECTIVE: To investigate effects of ulipristal acetate on health-related quality of life (QOL)
and symptom severity in women with symptomatic uterine leiomyomas and abnormal uterine …